2 June - 28 July 2020

FCG/YCP Webinar Series

Organised by:

SCI’s Fine Chemicals Group and Young Chemists’ Panel

Online Webinars - Tuesdays at 15:00 (UK Time)

Register for this series

Prices start from £0.00


The Fine Chemicals Group and Young Chemists’ Panel of the SCI are pleased to announce a series of free webinars that showcase the quality of chemistry presented at their meetings to a wider audience and to provide interesting subject based content during a time when face to face conferences and learning is restricted. This free webinar series will refresh content previously seen at Fine Chemicals Group and Young Chemists’ Panel meetings and include developments, updates and opportunities to find out more. The committees are planning to produce a weekly on-line event starting from early May.

  • Each Webinar will feature a single 45 minute or two paired 25 minute presentations, allowing plenty of time for discussion and questions from the audience.

  • The webinars will run on Tuesday afternoons at 15:00 (UK time).Once an attendee registers on this page you will be sent details of all upcoming webinars as they are announced so you can then join any lectures of the series that you are interested in.

  • Catherine Alder

    GlaxoSmithKline (GSK) - Tuesday 2 June

    Catherine graduated from the University of Sheffield, and joined GSK Stevenage in 2006, after a period at MSD. Since joining GSK she initially worked in various Med chem groups.

    - In 2012 she joined Green Chemistry, working on both in-house and external collaborations, such as IMI:Chem21 project to improve the environmental impact of routes to APIs.

    - Catherine works closely with Med Chem to introduce changes earlier to ensure a longer term impact, and looking for opportunities to try newer technologies such as flow chemistry, synthetic biochemistry, or working with atom efficient gases.

    Jennifer Johnston

    MSD - Tuesday 2 June

    - Originally from the UK; education completed at Uni of Birmingham and Oxford University
    - Following PhD, moved to the USA to pursue postdoctoral studies at Johns Hopkins University in Baltimore, then Mount Sinai School of Medicine in New York
    - 2014 - joined the Computational and Structural Chemistry department at MSD in New Jersey, USA, and is currently working on discovery targets in the oncology space

    Douglas Kell

    Douglas Kell

    University of Liverpool - Tuesday 9 June

    Research Chair in Systems Biology
    Present research topics include
    - De-orphanising transporters
    - Synthetic biology
    - Enzyme discovery
    - Dormant microbes in chronic disease
    - Deep learning

    Matthew Burns

    AstraZeneca - Tuesday 16 June

    - After an undergraduate degree in chemistry at the University of Bristol Matt joined Prof. V. Aggarwal for PhD developing reactions involving the homologation of boronic esters.
    - After his PhD, he was awarded a Marie-Curie postdoctoral fellowship to work at Colorado State University. Working with Prof. T. Rovis, he conducted research into the preparation and reactivity of - artificial metalloenzymes.
    - A postdoc with Prof. M. Gaunt at the University of Cambridge brought Matt back to the UK. After many years in academia Matt finally got a real job and now is working as a Senior Scientist in Chemical Development at AstraZeneca.

    Jean M

    Jean-Marc Henry

    AstraZeneca - Tuesday 16 June

    - Undergraduate in France, at the ECPM of Strasbourg and as an exchange student at the NTU of Singapore.
    - PhD in Manchester UK, developing halogenating enzymes and their integration with palladium chemistry.
    - Medicinal chemist at Redx Pharma.
    - Process chemist at AstraZeneca since 2018.

    Lars Barfacker

    Lars Bärfacker

    Bayer - Tuesday 23 June

    - 2000 - joined Bayer HealthCare (Wuppertal) as a Medicinal chemist. contributed to drug discovery programs including virology, COPD, CNS, cardiovascular disease and ophthalmology.
    - 2008 - received the Bayer Global Drug Discovery award (most prestigious award of Bayer to its scientists).
    - 2011 - moved to Berlin to dedicate work at Bayer towards oncological therapies.
    - 2014 – returned to Wuppertal to work on cross-functional aspects of drug discovery and drug delivery
    - 2014 - received Otto-Bayer-Medal and awarded as one of the top investors of Life-Science-Collaboration program in 2019 .

    Kevin Lam

    University of Greenwich - Tuesday 30 June

    - 2010 - received PhD in Medicinal & Synthetic Organic Chemistry from Catholic University of Louvain, Belgium. His doctoral work explored the use of electrochemistry and photochemistry as green alternatives to activate organic molecules

    - Post PhD - moved to the University of Vermont where his research focused on applying analytical/physical electrochemistry alongside spectroscopy to study the complex redox behaviour of organometallic compounds

    - 2013 - accepted position of Assistant Professor at Nazarbayev University in Kazakhstan

    2017 - joined University of Greenwich as a Reader

    Consecutive Tuesdays

    Webinars will last for a maximum of 1hr 15 minutes and will take place from 15:00 (UK time) each week on a Tuesday afternoon.

    Lectures are tentatively scheduled for the following dates with connection details provided 2 days before the webinar takes place. Registrations will be accepted until 12:00 (UK time) on the day of the webinar.

    Tuesday 2 June (15.00 UK time) - A 3-way BET to scale up a trans-disubstituted dihydrobenzofuran active bromodomain inhibitor
    Catherine Alder, GlaxoSmithKline (GSK)

    Tuesday 2 June (15.00 UK time) - A Multi-Pronged Approach to Targeting GPR40 for Diabetes
    Jennifer Johnston, MSD

    Tuesday 9 June (15.00 UK time) - How drugs really get into cells: why ‘passive permeability’ is a myth
    Douglas Kell, University of Liverpool
    Tuesday 16 June (15.00 UK time) - AZD5718 - Route design to manufacture - the story of a small heterocycle
    Matthew Burns, AstraZeneca

    Tuesday 16 June (15.00 UK time) - DEA boronic esters: Application to AZD5718
    Jean-Marc Henry, AstraZeneca

    Tuesday 23 June (15.00 UK time) - Discovery of Finerenone – A MR antagonist for the treatment of cardiorenal diseases
    Lars Bärfacker, Bayer

    Tuesday 30 June (15.00 UK time) - Electrons, Cations and Radicals – An Electrifying Journey
    Kevin Lam, University of Greenwich


    Further dates will be added, so please check the webpage on a weekly basis.


    If you are interested in sponsoring the SCI’s webinar programme, please email conferences@soci.org.

    Conference Team

    Tel: +44 (0)20 7598 1561
    Email: conferences@soci.org


    These events are free to attend

    Become an SCI Member and save on this and future events

    See Membership Options

    Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations

    Booking Process

    Read our event booking terms and conditions